|
1
|
Klein MJ and Siegal GP: Osteosarcoma:
Anatomic and histologic variants. Am J Clin Pathol. 125:555–581.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Neklyudova O, Arlt MJ, Brennecke P, Thelen
M, Gvozdenovic A, Kuzmanov A, Robl B, Botter SM, Born W and Fuchs
B: Altered CXCL12 expression reveals a dual role of CXCR4 in
osteosarcoma primary tumor growth and metastasis. J Cancer Res Clin
Oncol. 142:1739–1750. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zandueta C, Ormazábal C, Perurena N,
Martínez-Canarias S, Zalacaín M, Julián MS, Grigoriadis AE,
Valencia K, Campos-Laborie FJ, Jde L Rivas, et al: Matrix-Gla
protein promotes osteosarcoma lung metastasis and associates with
poor prognosis. J Pathol. 239:438–449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qu L and Liu B: Cyclooxygeanse-2 promotes
metastasis in osteosarcoma. Cancer Cell Int. 15:692015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weekes D, Kashima TG, Zandueta C, Perurena
N, Thomas DP, Sunters A, Vuillier C, Bozec A, El-Emir E, Miletich
I, et al: Regulation of osteosarcoma cell lung metastasis by the
c-Fos/AP-1 target FGFR1. Oncogene. 35:2852–2861. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gorlick R, Anderson P, Andrulis I, Arndt
C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D,
et al: Biology of childhood osteogenic sarcoma and potential
targets for therapeutic development: Meeting summary. Clin Cancer
Res. 9:5442–5453. 2003.PubMed/NCBI
|
|
7
|
Selvarajah GT, Kirpensteijn J, van
Wolferen ME, Rao NA, Fieten H and Mol JA: Gene expression profiling
of canine osteosarcoma reveals genes associated with short and long
survival times. Mol Cancer. 8:722009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wolf M, El-Rifai W, Tarkkanen M, Kononen
J, Serra M, Eriksen EF, Elomaa I, Kallioniemi A, Kallioniemi OP and
Knuutila S: Novel findings in gene expression detected in human
osteosarcoma by cDNA microarray. Cancer Genet Cytogenet.
123:128–132. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang N, Xie T, Xian M, Wang YJ, Li HY,
Ying MD and Ye ZM: SIRT1 promotes metastasis of human osteosarcoma
cells. Oncotarget. 7:79654–79669. 2016.PubMed/NCBI
|
|
10
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lammers G, Gilissen C, Nillesen ST,
Uijtdewilligen PJ, Wismans RG, Veltman JA, Daamen WF and van
Kuppevelt TH: High density gene expression microarrays and gene
ontology analysis for identifying processes in implanted tissue
engineering constructs. Biomaterials. 31:8299–8312. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wixon J and Kell D: The Kyoto encyclopedia
of genes and genomes-KEGG. Yeast. 17:48–55. 2000.PubMed/NCBI
|
|
14
|
Lu J, Song G, Tang Q, Zou C, Han F, Zhao
Z, Yong B, Yin J, Xu H, Xie X, et al: IRX1 hypomethylation promotes
osteosarcoma metastasis via induction of CXCL14/NF-κB signaling. J
Clin Invest. 125:1839–1856. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siegel HJ and Pressey JG: Current concepts
on the surgical and medical management of osteosarcoma. Expert Rev
Anticancer Ther. 8:1257–1269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang B, Li C and Zhao J: Identification
of key pathways and genes in colorectal cancer using bioinformatics
analysis. Med Oncol. 33:1112016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yin F, Shu L, Liu X, Li T, Peng T, Nan Y,
Li S, Zeng X and Qiu X: Microarray-based identification of genes
associated with cancer progression and prognosis in hepatocellular
carcinoma. J Exp Clin Cancer Res. 35:1272016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hollenstein K, Dawson RJ and Locher KP:
Structure and mechanism of ABC transporter proteins. Curr Opin
Struct Biol. 17:412–418. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yen MR, Choi J and Saier MH Jr:
Bioinformatic analyses of transmembrane transport: Novel software
for deducing protein phylogeny, topology and evolution. J Mol
Microbiol Biotechnol. 17:163–176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qiu J, Zhang W, Xia Q, Liu F, Li L, Zhao
S, Gao X, Zang C, Ge R and Sun Y: RNA sequencing identifies crucial
genes in papillary thyroid carcinoma (PTC) progression. Exp Mol
Pathol. 100:151–159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee MY and Shen MR: Epithelial-mesenchymal
transition in cervical carcinoma. Am J Transl Res. 4:1–13.
2012.PubMed/NCBI
|
|
23
|
Fester L, Zhou L, Ossig C, Labitzke J,
Bläute C, Bader M, Vollmer G, Jarry H and Rune GM: Synaptopodin is
regulated by aromatase activity. J Neurochem. 140:126–139. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bolufer P, Ricart E, Lluch A, Vazquez C,
Rodriguez A, Ruiz A, Llopis F, Garcia-Conde J and Romero R:
Aromatase activity and estradiol in human breast cancer: Its
relationship to estradiol and epidermal growth factor receptors and
to tumor-node-metastasis staging. J Clin Oncol. 10:438–446. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hammer A and Diakonova M:
Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK
dephosphorylation, breast cancer cell motility, invasion and
metastasis. BMC Cell Biol. 17:312016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsieh SY, He JR, Hsu CY, Chen WJ, Bera R,
Lin KY, Shih TC, Yu MC, Lin YJ, Chang CJ, et al:
Neuregulin/erythroblastic leukemia viral oncogene homolog 3
autocrine loop contributes to invasion and early recurrence of
human hepatoma. Hepatology. 53:504–516. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Noguti J, De Moura CF, De Jesus GP, Da
Silva VH, Hossaka TA, Oshima CT and Ribeiro DA: Metastasis from
oral cancer: An overview. Cancer Genomics Proteomics. 9:329–335.
2012.PubMed/NCBI
|
|
28
|
Aviezer D, Cotton S, David M, Segev A,
Khaselev N, Galili N, Gross Z and Yayon A: Porphyrin analogues as
novel antagonists of fibroblast growth factor and vascular
endothelial growth factor receptor binding that inhibit endothelial
cell proliferation, tumor progression, and metastasis. Cancer Res.
60:2973–2980. 2000.PubMed/NCBI
|
|
29
|
Giubellino A, Gao Y, Lee S, Lee MJ,
Vasselli JR, Medepalli S, Trepel JB, Burke TR Jr and Bottaro DP:
Inhibition of tumor metastasis by a growth factor receptor bound
protein 2 Src homology 2 domain-binding antagonist. Cancer Res.
67:6012–6016. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Ou ZL, Hou YF, Luo JM, Shen ZZ,
Ding J and Shao ZM: Enhanced expression of Duffy antigen receptor
for chemokines by breast cancer cells attenuates growth and
metastasis potential. Oncogene. 25:7201–7211. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Case LB and Waterman CM: Integration of
actin dynamics and cell adhesion by a three-dimensional,
mechanosensitive molecular clutch. Nat Cell Biol. 17:955–963.
2015.PubMed/NCBI
|
|
32
|
Sulzmaier FJ, Jean C and Schlaepfer DD:
FAK in cancer: Mechanistic findings and clinical applications. Nat
Rev Cancer. 14:598–610. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kishi T, Mayanagi T, Iwabuchi S, Akasaka T
and Sobue K: Myocardin-related transcription factor A (MRTF-A)
activity-dependent cell adhesion is correlated to focal adhesion
kinase (FAK) activity. Oncotarget. 7:72113–72130. 2016.PubMed/NCBI
|
|
34
|
Mendoza P, Ortiz R, Díaz J, Quest AF,
Leyton L, Stupack D and Torres VA: Rab5 activation promotes focal
adhesion disassembly, migration and invasiveness in tumor cells. J
Cell Sci. 126:3835–3847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Salem I, Alsalahi M, Chervoneva I, Aburto
LD, Addya S, Ott GR, Ruggeri BA, Cristofanilli M and Fernandez SV:
The effects of CEP-37440, an inhibitor of focal adhesion kinase, in
vitro and in vivo on inflammatory breast cancer cells. Breast
Cancer Res. 18:372016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Riedl JA, Brandt DT, Batlle E, Price LS,
Clevers H and Bos JL: Down-regulation of Rap1 activity is involved
in ephrinB1-induced cell contraction. Biochem J. 389:465–469. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Z, Liu XB, Liu YH, Xue YX, Wang P, Liu
LB, Yao YL and Ma J: Functions for the cAMP/Epac/Rap1 signaling
pathway in low-dose endothelial monocyte-activating
polypeptide-II-induced opening of blood-tumor barrier. J Mol
Neurosci. 57:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Leblanc R and Peyruchaud O: The role of
platelets and megakaryocytes in bone metastasis. J Bone Oncol.
5:109–111. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen XS, Li LY, Guan YD, Yang JM and Cheng
Y: Anticancer strategies based on the metabolic profile of tumor
cells: Therapeutic targeting of the Warburg effect. Acta Pharmacol
Sin. 37:1013–1019. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cohen-Solal KA, Boregowda RK and Lasfar A:
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving
force for tumor progression. Mol Cancer. 14:1372015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu JF, Tsao YT and Hou CH: Amphiregulin
enhances intercellular adhesion molecule-1 expression and promotes
tumor metastasis in human osteosarcoma. Oncotarget. 6:40880–40895.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang Y, Gao Z, Ma Y, Teng H, Liu Z, Wei H,
Lu Y, Cheng X, Hou L and Zou X: Fucoidan inhibits lymphangiogenesis
by downregulating the expression of VEGFR3 and PROX1 in human
lymphatic endothelial cells. Oncotarget. 7:38025–38035. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ohguchi S, Nakatsukasa H, Higashi T,
Ashida K, Nouso K, Ishizaki M, Hino N, Kobayashi Y, Uematsu S and
Tsuji T: Expression of alpha-fetoprotein and albumin genes in human
hepatocellular carcinomas: Limitations in the application of the
genes for targeting human hepatocellular carcinoma in gene therapy.
Hepatology. 27:599–607. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nojiri S and Joh T: Albumin suppresses
human hepatocellular carcinoma proliferation and the cell cycle.
Int J Mol Sci. 15:5163–5174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gai JQ, Sheng X, Qin JM, Sun K, Zhao W and
Ni L: The effect and mechanism of bufalin on regulating
hepatocellular carcinoma cell invasion and metastasis via
Wnt/β-catenin signaling pathway. Int J Oncol. 48:338–348. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chou HC, Sheu JC, Huang GT, Wang JT and
Chen DS: Albumin messenger RNA is not specific for circulating
hepatoma cells. Gastroenterology. 107:630–631. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang J, Li S, Wang B, Wu Y, Chen Z, Lv M,
Lin Y and Yang J: Potential biomarkers for anti-EGFR therapy in
metastatic colorectal cancer. Tumour Biol. 37:11645–11655. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zheng LS, Yang JP, Cao Y, Peng LX, Sun R,
Xie P, Wang MY, Meng DF, Luo DH, Zou X, et al: SPINK6 promotes
metastasis of nasopharyngeal carcinoma via binding and activation
of epithelial growth factor receptor. Cancer Res. 77:579–589. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Day KC, Hiles GL, Kozminsky M, Dawsey SJ,
Paul A, Broses LJ, Shah R, Kunja LP, Hall C, Palanisamy N, et al:
HER2 and EGFR overexpression support metastatic progression of
prostate cancer to bone. Cancer Res. 77:74–85. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang M, Gong W, Zuo B, Chu B, Tang Z,
Zhang Y, Yang Y, Zhou D, Weng M, Qin Y, et al: The microRNA miR-33a
suppresses IL-6-induced tumor progression by binding Twist in
gallbladder cancer. Oncotarget. 7:78640–78652. 2016.PubMed/NCBI
|
|
51
|
Bertucci F, Finetti P, Guille A, Adélaïde
J, Garnier S, Carbuccia N, Monneur A, Charafe-Jauffret E, Goncalves
A, Viens P, et al: Comparative genomic analysis of primary tumors
and metastases in breast cancer. Oncotarget. 7:27208–27219. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Schade B, Lesurf R, Sanguin-Gendreau V,
Bui T, Deblois G, O'Toole SA, Millar EK, Zardawi SJ, Lopez-Knowles
E, Sutherland RL, et al: β-Catenin signaling is a critical event in
ErbB2-mediated mammary tumor progression. Cancer Res. 73:4474–4487.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang MH, Shen QH, Qin ZM, Wang QL and
Chen X: Systematic tracking of disrupted modules identifies
significant genes and pathways in hepatocellular carcinoma. Oncol
Lett. 12:3285–3295. 2016.PubMed/NCBI
|
|
54
|
Zhao Y, Xue F, Sun J, Guo S, Zhang H, Qiu
B, Geng J, Gu J, Zhou X, Wang W, et al: Genome-wide methylation
profiling of the different stages of hepatitis B virus-related
hepatocellular carcinoma development in plasma cell-free DNA
reveals potential biomarkers for early detection and high-risk
monitoring of hepatocellular carcinoma. Clin Epigenetics. 6:302014.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Myers JS, von Lersner AK and Sang QX:
Proteomic upregulation of fatty acid synthase and fatty acid
binding protein 5 and identification of cancer- and race-specific
pathway associations in human prostate cancer tissues. J Cancer.
7:1452–1464. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Akkiprik M, Peker I, Özmen T, Amuran GG,
Güllüoğlu BM, Kaya H and Özer A: Identification of differentially
expressed IGFBP5-related genes in breast cancer tumor tissues using
cDNA microarray experiments. Genes (Basel). 6:1201–1214. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang DD, Liu ZW, Han MM, Zhu ZM, Tu YL,
Dou CQ, Jin X, Cai SW and Du N: Microarray based analysis of gene
expression patterns in pancreatic neuroendocrine tumors. Eur Rev
Med Pharmacol Sci. 19:3367–3374. 2015.PubMed/NCBI
|
